2019

1. Safety and Efficacy of Crizotinib in Patients With Advanced or Metastatic ROS1-Rearranged Lung Cancer (EUCROSS): A European Phase II Clinical Trial

   Journal of Thoracic Oncology, Vol. 14, Núm. 7, pp. 1266-1276